MacroGenics IncNASDAQ:MGNX
- LAST PRICE4.5300
- TODAY'S CHANGE (%)-0.1400 (-2.9979%)
- Bid / Lots4.5300/ 2
- Ask / Lots4.8200/ 1
- Open / Previous Close4.6300 / 4.6700
- Day Range
- 52 Week Range
- Volume957,006
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MGNX |
|---|---|---|
| 09:32 ET | 13211 | 4.57 |
| 09:34 ET | 2082 | 4.625 |
| 09:36 ET | 5479 | 4.64 |
| 09:38 ET | 1913 | 4.64 |
| 09:39 ET | 2049 | 4.65 |
| 09:41 ET | 4931 | 4.64 |
| 09:43 ET | 3191 | 4.6883 |
| 09:45 ET | 948 | 4.66 |
| 09:48 ET | 450 | 4.64 |
| 09:50 ET | 200 | 4.64 |
| 09:52 ET | 4113 | 4.66 |
| 09:54 ET | 4841 | 4.64 |
| 09:56 ET | 2474 | 4.64 |
| 09:57 ET | 3900 | 4.65 |
| 09:59 ET | 1300 | 4.66 |
| 10:01 ET | 7089 | 4.68 |
| 10:03 ET | 6450 | 4.64 |
| 10:06 ET | 5708 | 4.63 |
| 10:08 ET | 4486 | 4.64 |
| 10:10 ET | 2007 | 4.65 |
| 10:12 ET | 1255 | 4.65 |
| 10:14 ET | 900 | 4.64 |
| 10:15 ET | 400 | 4.67 |
| 10:17 ET | 1707 | 4.68 |
| 10:19 ET | 807 | 4.6999 |
| 10:21 ET | 1607 | 4.72 |
| 10:24 ET | 700 | 4.75 |
| 10:26 ET | 700 | 4.745 |
| 10:28 ET | 1397 | 4.74 |
| 10:30 ET | 5740 | 4.77 |
| 10:32 ET | 2188 | 4.76 |
| 10:33 ET | 1805 | 4.74 |
| 10:35 ET | 900 | 4.73 |
| 10:37 ET | 2027 | 4.75 |
| 10:39 ET | 925 | 4.76 |
| 10:42 ET | 3885 | 4.7683 |
| 10:44 ET | 1420 | 4.769 |
| 10:46 ET | 3402 | 4.77 |
| 10:48 ET | 7536 | 4.785 |
| 10:50 ET | 1650 | 4.75 |
| 10:51 ET | 14655 | 4.76 |
| 10:53 ET | 4000 | 4.73 |
| 10:55 ET | 13115 | 4.6831 |
| 10:57 ET | 2680 | 4.68 |
| 11:00 ET | 3338 | 4.67 |
| 11:02 ET | 600 | 4.65 |
| 11:04 ET | 3684 | 4.68 |
| 11:06 ET | 300 | 4.675 |
| 11:08 ET | 793 | 4.6899 |
| 11:09 ET | 1619 | 4.6988 |
| 11:11 ET | 650 | 4.69 |
| 11:13 ET | 1300 | 4.7 |
| 11:15 ET | 449 | 4.71 |
| 11:18 ET | 911 | 4.7183 |
| 11:20 ET | 518 | 4.71 |
| 11:22 ET | 409 | 4.701 |
| 11:24 ET | 1675 | 4.72 |
| 11:27 ET | 100 | 4.72 |
| 11:29 ET | 4261 | 4.69 |
| 11:31 ET | 1234 | 4.6801 |
| 11:33 ET | 300 | 4.69 |
| 11:36 ET | 1093 | 4.688 |
| 11:38 ET | 300 | 4.675 |
| 11:40 ET | 5500 | 4.69 |
| 11:44 ET | 4854 | 4.7 |
| 11:45 ET | 250 | 4.69 |
| 11:47 ET | 1758 | 4.69 |
| 11:49 ET | 200 | 4.68 |
| 11:51 ET | 1200 | 4.68 |
| 11:54 ET | 400 | 4.68 |
| 11:56 ET | 1839 | 4.67 |
| 11:58 ET | 1159 | 4.66 |
| 12:00 ET | 525 | 4.68 |
| 12:02 ET | 100 | 4.66 |
| 12:03 ET | 578 | 4.6688 |
| 12:05 ET | 900 | 4.67 |
| 12:07 ET | 600 | 4.675 |
| 12:12 ET | 1680 | 4.66 |
| 12:14 ET | 3051 | 4.66 |
| 12:16 ET | 200 | 4.655 |
| 12:18 ET | 3500 | 4.6599 |
| 12:20 ET | 500 | 4.6678 |
| 12:21 ET | 521 | 4.6677 |
| 12:23 ET | 1000 | 4.675 |
| 12:25 ET | 900 | 4.675 |
| 12:27 ET | 900 | 4.68 |
| 12:30 ET | 400 | 4.69 |
| 12:32 ET | 204 | 4.6717 |
| 12:34 ET | 300 | 4.68 |
| 12:36 ET | 2843 | 4.66 |
| 12:38 ET | 2244 | 4.66 |
| 12:39 ET | 707 | 4.66 |
| 12:43 ET | 1181 | 4.654 |
| 12:45 ET | 637 | 4.65 |
| 12:48 ET | 620 | 4.6599 |
| 12:50 ET | 1400 | 4.645 |
| 12:52 ET | 12534 | 4.66 |
| 12:54 ET | 1839 | 4.665 |
| 12:56 ET | 2112 | 4.66 |
| 12:57 ET | 600 | 4.65 |
| 12:59 ET | 1624 | 4.65 |
| 01:01 ET | 328 | 4.645 |
| 01:03 ET | 1000 | 4.65 |
| 01:06 ET | 100 | 4.64 |
| 01:08 ET | 600 | 4.64 |
| 01:10 ET | 200 | 4.65 |
| 01:12 ET | 600 | 4.65 |
| 01:14 ET | 3063 | 4.67 |
| 01:15 ET | 200 | 4.6783 |
| 01:19 ET | 2630 | 4.65 |
| 01:21 ET | 263 | 4.64 |
| 01:24 ET | 100 | 4.64 |
| 01:28 ET | 2400 | 4.645 |
| 01:30 ET | 4551 | 4.64 |
| 01:32 ET | 480 | 4.64 |
| 01:33 ET | 400 | 4.64 |
| 01:35 ET | 3030 | 4.64 |
| 01:37 ET | 1500 | 4.64 |
| 01:39 ET | 2190 | 4.64 |
| 01:42 ET | 2236 | 4.64 |
| 01:44 ET | 200 | 4.64 |
| 01:46 ET | 920 | 4.64 |
| 01:48 ET | 2470 | 4.65 |
| 01:50 ET | 1301 | 4.66 |
| 01:51 ET | 962 | 4.65 |
| 01:53 ET | 1199 | 4.64 |
| 01:55 ET | 2620 | 4.645 |
| 01:57 ET | 2900 | 4.61 |
| 02:00 ET | 789 | 4.605 |
| 02:02 ET | 7926 | 4.58 |
| 02:04 ET | 4640 | 4.58 |
| 02:06 ET | 5056 | 4.58 |
| 02:08 ET | 600 | 4.57 |
| 02:09 ET | 1713 | 4.58 |
| 02:11 ET | 599 | 4.58 |
| 02:13 ET | 3958 | 4.58 |
| 02:15 ET | 400 | 4.58 |
| 02:18 ET | 315 | 4.5712 |
| 02:20 ET | 1000 | 4.58 |
| 02:22 ET | 2516 | 4.57 |
| 02:24 ET | 1633 | 4.57 |
| 02:26 ET | 4218 | 4.5792 |
| 02:27 ET | 7557 | 4.55 |
| 02:29 ET | 4479 | 4.54 |
| 02:31 ET | 7158 | 4.54 |
| 02:33 ET | 1300 | 4.52 |
| 02:36 ET | 1942 | 4.53 |
| 02:38 ET | 1090 | 4.54 |
| 02:40 ET | 2538 | 4.54 |
| 02:42 ET | 4016 | 4.58 |
| 02:44 ET | 3600 | 4.59 |
| 02:45 ET | 550 | 4.6 |
| 02:47 ET | 5229 | 4.58 |
| 02:49 ET | 8584 | 4.55 |
| 02:51 ET | 5400 | 4.54 |
| 02:54 ET | 3300 | 4.54 |
| 02:56 ET | 10672 | 4.54 |
| 02:58 ET | 3407 | 4.51 |
| 03:00 ET | 10436 | 4.51 |
| 03:02 ET | 6726 | 4.52 |
| 03:03 ET | 3133 | 4.535 |
| 03:05 ET | 900 | 4.545 |
| 03:07 ET | 1280 | 4.555 |
| 03:09 ET | 6197 | 4.5501 |
| 03:12 ET | 3804 | 4.54 |
| 03:14 ET | 2499 | 4.55 |
| 03:16 ET | 1223 | 4.55 |
| 03:18 ET | 1026 | 4.55 |
| 03:23 ET | 3851 | 4.545 |
| 03:25 ET | 900 | 4.555 |
| 03:27 ET | 8468 | 4.5421 |
| 03:30 ET | 1219 | 4.54 |
| 03:32 ET | 6023 | 4.55 |
| 03:34 ET | 4957 | 4.545 |
| 03:36 ET | 755 | 4.54 |
| 03:38 ET | 5300 | 4.545 |
| 03:39 ET | 835 | 4.545 |
| 03:41 ET | 48937 | 4.58 |
| 03:43 ET | 4924 | 4.56 |
| 03:45 ET | 2199 | 4.565 |
| 03:48 ET | 8889 | 4.555 |
| 03:50 ET | 3103 | 4.56 |
| 03:52 ET | 4742 | 4.555 |
| 03:54 ET | 10971 | 4.555 |
| 03:56 ET | 11639 | 4.545 |
| 03:57 ET | 17136 | 4.53 |
| 03:59 ET | 244526 | 4.53 |
Today
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX, from 3 hours ago by Dow Jones
3 hours ago by Dow JonesMacroGenics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - MGNX, from 4 hours ago by Dow Jones
4 hours ago by Dow JonesThe Schall Law Firm has initiated an investigation into claims against MacroGenics, Inc. (MGNX) and is urging its investors to reach out, from 4 hours ago by Dow Jones
4 hours ago by Dow Jones
Yesterday
MacroGenics, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - MGNX, from 12:33PM ET on Thursday Jun 06, 2024 by Dow Jones
12:33PM ET on Thursday Jun 06, 2024 by Dow JonesThe Schall Law Firm Begins Inquiry Into Allegations Against MacroGenics, Inc. (MGNX) And Encourages Its Investors To Make Contact, from 12:16PM ET on Thursday Jun 06, 2024 by Dow Jones
12:16PM ET on Thursday Jun 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
MacroGenics Inc | 256.2M | -12.1x | --- |
Innate Pharma SA | 221.6M | -28.4x | --- |
Adaptimmune Therapeutics PLC | 288.8M | -1.4x | --- |
AVITA Medical Inc | 247.9M | -5.2x | --- |
Poseida Therapeutics Inc | 289.9M | -2.3x | --- |
Codexis Inc | 238.5M | -3.5x | --- |
Company Information
MacroGenics, Inc. is a biopharmaceutical company focused on developing and commercializing monoclonal antibody-based therapeutics for the treatment of cancer. It generates its pipeline of product candidates primarily from its suite of antibody-based technology platforms, which have applicability across broad therapeutic domains. It is developing product candidates that target various tumor-associated antigens and immune checkpoint molecules. Its lead pipeline program is vobramitamab duocarmazine (vobra duo), an antibody-drug conjugate (ADC) that targets B7-H3, a molecule in the B7 family of immune regulator proteins that is expressed by several different tumor types. Its clinical pipeline includes two product candidates based on its, bispecific DART technology that co-engages both PD-1 and other checkpoint molecules. These candidates include lorigerlimab and tebotelimab. In addition, it is developing MGD024, a bispecific DART molecule. It is also developing various other programs.
Contact Information
- Headquarters
- 9704 Medical Center DriveROCKVILLE, MD, United States 20850
- Phone
- 301-251-5172
- Fax
- 301-251-5321
Executives
- Independent Chairman of the Board
- William Heiden
- President, Chief Executive Officer, Director
- Scott Koenig
- Chief Financial Officer, Senior Vice President, Corporate Secretary
- James Karrels
- Chief Operating Officer
- Eric Risser
- Senior Vice President - Research, Chief Scientific Officer
- Ezio Bonvini
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $256.2M |
|---|---|
Revenue (TTM) | $43.4M |
Shares Outstanding | 62.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.00 |
EPS | $-0.38 |
Book Value | $2.46 |
P/E Ratio | -12.1x |
Price/Sales (TTM) | 5.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -75.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
